Cited 0 times in 
Cited 0 times in 
Co- occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): Biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trial
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2023-06-02T00:45:36Z | - |
| dc.date.available | 2023-06-02T00:45:36Z | - |
| dc.date.issued | 2022-06 | - |
| dc.identifier.issn | 0923-7534 | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194403 | - |
| dc.description.statementOfResponsibility | restriction | - |
| dc.language | English | - |
| dc.publisher | Oxford University Press | - |
| dc.relation.isPartOf | ANNALS OF ONCOLOGY | - |
| dc.rights | CC BY-NC-ND 2.0 KR | - |
| dc.title | Co- occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): Biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trial | - |
| dc.type | Article | - |
| dc.contributor.college | College of Medicine (의과대학) | - |
| dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
| dc.contributor.googleauthor | Y. Janjigian | - |
| dc.contributor.googleauthor | S. Rha | - |
| dc.contributor.googleauthor | D. Oh | - |
| dc.contributor.googleauthor | M. Díez García | - |
| dc.contributor.googleauthor | H. van Laarhoven | - |
| dc.contributor.googleauthor | Y. Chao | - |
| dc.contributor.googleauthor | M. Di Bartolomeo | - |
| dc.contributor.googleauthor | N. Haj Mohammad | - |
| dc.contributor.googleauthor | W. Zhong | - |
| dc.contributor.googleauthor | E. Croydon | - |
| dc.contributor.googleauthor | F. Cecchi | - |
| dc.contributor.googleauthor | J. Lee | - |
| dc.identifier.doi | 10.1016/j.annonc.2022.04.406 | - |
| dc.relation.journalcode | J00171 | - |
| dc.identifier.eissn | 1569-8041 | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0923753422010961 | - |
| dc.citation.volume | 33 | - |
| dc.citation.number | Suppl 4 | - |
| dc.citation.startPage | S358 | - |
| dc.citation.endPage | S359 | - |
| dc.identifier.bibliographicCitation | ANNALS OF ONCOLOGY, Vol.33(Suppl 4) : S358-S359, 2022-06 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.